tranexamic acid in the control of uterine atony during labor
نویسندگان
چکیده
results hemoglobin level was 9.9 ± 5.1 in the control group six hours after hemorrhage while it was 8.10 ± 2.1 in the treatment group (p = 0.004). hemoglobin level was 5.8 ± 4.1 in the control who did not receive transfusion of blood products during the first 24 hours after hemorrhage, while this level was 7.9 ± 4.1 in the treatment group (p = 0.001). the amount of bleeding significantly declined in the intervention group compared to the control group (p < 0.001). moreover, the need for transfusion of blood products decreased by a third (p < 0.001) while the number of hospitalization days significantly decreased as well (p < 0.04). objectives the aim of this study was to determine the effect of tranexamic acid on the control of uterine atony during labor. patients and methods a randomized clinical trial was conducted on 90 pregnant women who had uterine atony in qazvin, during the year 2012. the control group (n = 45) received the routine treatment of uterine atony. the second group (n = 45), in addition to the routine treatments, received 1 gram of tranexamic acid diluted in 100 ml saline of 5% dextrose in water by intravenous infusion within 10 minutes. the amount of blood loss, changes in hemoglobin level, need for surgical intervention and transfusion of blood products and duration of hospitalization were compared between the two groups. data were analyzed using the chi-square test and t test. background death from hemorrhage is still the leading cause of maternal mortality. conclusions tranexamic acid can significantly reduce the rate of postpartum hemorrhage.
منابع مشابه
Case Report: A Report of Tranexamic Acid Ampoule Effect on Uterine Atony After Normal Vaginal Delivery
PPH is one of three main causes of maternal mortality in the developing countries. Atony is responsible for 75-90 % of PPH. In the lack of essential actions for reparation there will be substantial increase of maternal deaths. Recently TXA benefits in reduction of PPH is considered by many researchers. TXA is a finaquinolysis inhibitor. It’s been years TXA is commonly used in surgeries such as ...
متن کاملthe effect of e-64 on the developmental competence of sheep cocs during in vitro maturation
in the present study, the effect of e-64 at different concentrations (0.5, 1, 5 and 10 µm) added to (1) the ivm medium on oocyte nuclear maturation and developmental competence of ovine oocytes, and (2) to the ivc medium on embryonic development of ovine embryos were investigated.
Uterine Atony: Management Strategies
It is estimated about 529,000 mothers die every year (World Health Organisation [WHO] 2005). Postpartum haemorrhage (PPH), a life-threatening condition, remains the major cause of maternal mortality worldwide (Pahlavan et al., 2001). Majority of these mortalities are from Asia (48%) and Africa (47.5%) with only the minority (less than 1%) from developed countries.(Ramanathan & Arulkumaran, 2006...
متن کاملThe Shape of Uterine Contractions and Labor Progress in the Spontaneous Active Labor
Background: Dystocia is the most common indication of primary cesarean section. The most common cause of dystocia is uterine dysfunction. In prolonged labor, more attention is usually paid to the fetus and pelvis rather than to the role of uterine contractions in a delivery. Therefore, we decided to determine the relationship between the labor progress and uterine contractions shapes.Methods: I...
متن کاملUterus Wrapping: A Novel Concept in the Management of Uterine Atony during Cesarean Delivery
Uterine atony during cesarean delivery is a serious cause of maternal morbidity and mortality. Management strategies include medical treatment with uterotonic agents, manual compression of the uterus, and interventional or surgical procedures. A novel technique to compress the uterus by wrapping it with an elastic bandage and its outcome in 3 cases of uterine atony during cesarean section are p...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
journal of biotechnology and health sciencesجلد ۲، شماره ۲، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023